Chicago Partners Investment Group LLC increased its holdings in Colgate-Palmolive Company (NYSE:CL – Free Report) by 26.3% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 28,514 shares of the company’s stock after buying an additional 5,940 shares during the period. Chicago Partners Investment Group LLC’s holdings in Colgate-Palmolive were worth $2,681,000 as of its most recent SEC filing.
Other hedge funds have also modified their holdings of the company. Compass Financial Management LLC increased its position in Colgate-Palmolive by 93.1% during the third quarter. Compass Financial Management LLC now owns 1,757 shares of the company’s stock worth $150,000 after buying an additional 847 shares in the last quarter. Rakuten Investment Management Inc. increased its position in Colgate-Palmolive by 9.3% during the 3rd quarter. Rakuten Investment Management Inc. now owns 140,679 shares of the company’s stock worth $12,163,000 after purchasing an additional 11,986 shares in the last quarter. AIA Group Ltd increased its position in Colgate-Palmolive by 140.5% during the 3rd quarter. AIA Group Ltd now owns 47,369 shares of the company’s stock worth $4,042,000 after purchasing an additional 27,670 shares in the last quarter. Provenance Wealth Advisors LLC acquired a new position in Colgate-Palmolive in the 3rd quarter valued at about $526,000. Finally, Integras Partners LLC lifted its holdings in Colgate-Palmolive by 0.6% in the 3rd quarter. Integras Partners LLC now owns 35,991 shares of the company’s stock valued at $3,071,000 after purchasing an additional 207 shares in the last quarter. 80.41% of the stock is owned by hedge funds and other institutional investors.
Colgate-Palmolive Stock Down 2.1%
Shares of NYSE:CL traded down $2.08 during midday trading on Friday, hitting $96.61. 5,464,263 shares of the company’s stock traded hands, compared to its average volume of 4,806,784. The company has a debt-to-equity ratio of 11.23, a quick ratio of 0.30 and a current ratio of 0.96. The company has a market cap of $76.80 billion, a PE ratio of 37.89, a P/E/G ratio of 4.55 and a beta of 0.31. The firm’s fifty day moving average price is $90.12 and its two-hundred day moving average price is $89.97. Colgate-Palmolive Company has a twelve month low of $75.96 and a twelve month high of $101.18.
Colgate-Palmolive (NYSE:CL – Get Free Report) last released its quarterly earnings results on Friday, October 30th. The company reported $0.97 earnings per share for the quarter, topping analysts’ consensus estimates of $0.93 by $0.04. Colgate-Palmolive had a return on equity of 607.88% and a net margin of 9.65%. The firm had revenue of $5.37 billion during the quarter, compared to analysts’ expectations of $5.34 billion. During the same quarter in the prior year, the business earned $0.91 EPS. Colgate-Palmolive’s quarterly revenue was up 4.6% compared to the same quarter last year. On average, equities research analysts anticipate that Colgate-Palmolive Company will post 3.91 EPS for the current fiscal year.
Colgate-Palmolive Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Tuesday, October 20th will be given a dividend of $0.53 per share. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date of this dividend is Tuesday, October 20th. Colgate-Palmolive’s payout ratio is presently 83.14%.
Wall Street Analysts Forecast Growth
A number of research firms have recently weighed in on CL. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a $101.00 price objective (up from $99.00) on shares of Colgate-Palmolive in a research report on Monday, August 3rd. Wells Fargo & Company lifted their price objective on Colgate-Palmolive from $90.00 to $95.00 and gave the company an “equal weight” rating in a research report on Monday, November 2nd. Evercore lifted their price target on Colgate-Palmolive from $100.00 to $101.00 and gave the company an “outperform” rating in a report on Thursday, October 8th. Barclays increased their price objective on shares of Colgate-Palmolive from $87.00 to $95.00 and gave the stock an “equal weight” rating in a report on Tuesday. Finally, Sanford C. Bernstein reissued a “market perform” rating on shares of Colgate-Palmolive in a research report on Thursday, August 13th. Thirteen investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $101.22.
Check Out Our Latest Research Report on CL
Insider Buying and Selling
In other Colgate-Palmolive news, insider John Hazlin sold 23,376 shares of the firm’s stock in a transaction on Wednesday, November 4th. The shares were sold at an average price of $99.15, for a total transaction of $2,317,730.40. Following the completion of the transaction, the insider directly owned 27,021 shares of the company’s stock, valued at $2,679,132.15. This trade represents a 46.38% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Noel R. Wallace sold 20,000 shares of the company’s stock in a transaction dated Thursday, November 5th. The shares were sold at an average price of $100.26, for a total transaction of $2,005,200.00. Following the completion of the sale, the chief executive officer owned 359,700 shares in the company, valued at approximately $36,063,522. This trade represents a 5.27% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders have sold 73,314 shares of company stock worth $7,212,109. 0.43% of the stock is currently owned by corporate insiders.
Colgate-Palmolive Company Profile
Colgate-Palmolive is a global consumer products company whose business spans oral care, personal care, home care and pet nutrition. Its products include toothpaste, toothbrushes, mouthwashes, soaps, shampoos, cleaning products and pet food.
The company’s best-known brands include Colgate, Palmolive, elmex, Softsoap, Ajax and Hill’s Pet Nutrition. It sells products through retail and other channels in markets around the world.
Founded in 1806 by William Colgate as a soap and candle business in New York City, the company has grown into an international manufacturer of household and personal care products.
See Also
- Five stocks we like better than Colgate-Palmolive
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
- Airbnb Defied a Brutal Tech Sell-Off, But Can Its Post-Earnings Rally Last?
- MarketBeat Week in Review – 11/2 – 11/6
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.
